Earkart Ltd Incorporates UK Subsidiary to Focus on Healthcare Services
Earkart Limited has established a new foreign subsidiary in the United Kingdom, dedicated to providing healthcare services and related products. The incorporation of Earkart Health Limited marks a strategic expansion for the company into the specialized healthcare sector.The subsidiary was formally incorporated in the United Kingdom on 08 June 2026. Earkart Health Limited is positioned within the Healthcare industry and has been established to undertake healthcare services, produce healthcare products, and conduct allied activities. The board noted that this business area remains consistent with the core business of Earkart Ltd.
The acquisition and investment transaction involve the subscription to initial paid-up share capital by Earkart Ltd in cash. The company holds a 65% stake in the newly incorporated entity.
Key details regarding the establishment of Earkart Health Limited are as follows:
| Particulars | Details |
|---|---|
| Subsidiary Name | Earkart Health Limited |
| Industry | Healthcare |
| Incorporation Date | 08 June 2026 in the United Kingdom |
| Shareholding Acquired | 65% |
| Shares Subscribed | 650 equity shares of GBP 10 each |
| Consideration | GBP 6,500/- cash |
Earkart Health Limited has authorized a share capital of GBP 10,000/-, with paid-up share capital also standing at GBP 10,000/-. The company acquired the shares at the face value of GBP 10/- per share.
Since Earkart Health Limited is a newly incorporated entity, turnover details for the last three years are not applicable, and the subsidiary currently does not have any active business operations.
Stock Price Movement
Earkart Ltd shares settled at ₹132.95 on Thursday, edging higher after gaining 2.27%. The stock traded within a notable intraday range, dipping as low as ₹125.00 and climbing to a high of ₹144.00.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.